Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP174375.RAzcv-EoTmczU38b-mymq9dAAySxmYXhu__nDaKL5sc4A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP174375.RAzcv-EoTmczU38b-mymq9dAAySxmYXhu__nDaKL5sc4A130_assertion type Assertion NP174375.RAzcv-EoTmczU38b-mymq9dAAySxmYXhu__nDaKL5sc4A130_head.
- NP174375.RAzcv-EoTmczU38b-mymq9dAAySxmYXhu__nDaKL5sc4A130_assertion description "[The aims of the study were (i) to assess the distribution of the angiotensin II type 1 receptor (AGTR1) gene 1166A/C polymorphism and two polymorphisms of the angiotensinogen (AGT) gene (Met235Thr and Thr174Met) in patients with ST-segment-elevation myocardial infarction (STEMI) who underwent coronary angiography, compared with healthy volunteers; (ii) to determine if there was any correlation between these polymorphisms and risk of STEMI; and (iii) to assess the association of the examined polymorphisms with such classic cardiovascular risk factors as hypertension, diabetes mellitus, obesity (based on a body mass index ?25?kg/m2), smoking, dyslipidemia, and family history of cardiovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP174375.RAzcv-EoTmczU38b-mymq9dAAySxmYXhu__nDaKL5sc4A130_provenance.
- NP174375.RAzcv-EoTmczU38b-mymq9dAAySxmYXhu__nDaKL5sc4A130_assertion evidence source_evidence_literature NP174375.RAzcv-EoTmczU38b-mymq9dAAySxmYXhu__nDaKL5sc4A130_provenance.
- NP174375.RAzcv-EoTmczU38b-mymq9dAAySxmYXhu__nDaKL5sc4A130_assertion SIO_000772 21657802 NP174375.RAzcv-EoTmczU38b-mymq9dAAySxmYXhu__nDaKL5sc4A130_provenance.
- NP174375.RAzcv-EoTmczU38b-mymq9dAAySxmYXhu__nDaKL5sc4A130_assertion wasDerivedFrom befree-20140225 NP174375.RAzcv-EoTmczU38b-mymq9dAAySxmYXhu__nDaKL5sc4A130_provenance.
- NP174375.RAzcv-EoTmczU38b-mymq9dAAySxmYXhu__nDaKL5sc4A130_assertion wasGeneratedBy ECO_0000203 NP174375.RAzcv-EoTmczU38b-mymq9dAAySxmYXhu__nDaKL5sc4A130_provenance.